1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

M T Cantorna, C E Hayes, H F DeLuca, M T Cantorna, C E Hayes, H F DeLuca

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an autoimmune disease believed to be a model for the human disease multiple sclerosis (MS). Induced by immunizing B10.PL mice with myelin basic protein (MBP), EAE was completely prevented by the administration of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]. 1,25-(OH)2D3 could also prevent the progression of EAE when administered at the appearance of the first disability symptoms. Withdrawal of 1,25-(OH)2D3 resulted in a resumption of the progression of EAE. Thus, the block by 1,25-(OH)2D3 is reversible. A deficiency of vitamin D resulted in an increased susceptibility to EAE. Thus, 1,25-(OH)2D3 or its analogs are potentially important for treatment of MS.

References

    1. Infect Immun. 1996 Apr;64(4):1100-9
    1. J Neuroimmunol. 1995 Sep;61(2):151-60
    1. Science. 1983 Sep 16;221(4616):1181-3
    1. J Clin Endocrinol Metab. 1983 Dec;57(6):1308-10
    1. J Clin Invest. 1984 Aug;74(2):657-61
    1. Cancer Res. 1984 Dec;44(12 Pt 1):5624-8
    1. J Clin Invest. 1987 Jun;79(6):1659-64
    1. J Nutr. 1987 May;117(5):857-65
    1. J Clin Endocrinol Metab. 1989 Jul;69(1):127-33
    1. J Clin Invest. 1991 Mar;87(3):1103-7
    1. Ann N Y Acad Sci. 1992 Sep 30;669:59-68; discussion 68-9
    1. Arch Biochem Biophys. 1993 May 15;303(1):98-106
    1. Immunol Lett. 1993 Feb;35(2):177-82
    1. Immunol Today. 1994 Aug;15(8):356-61
    1. Vitam Horm. 1994;49:281-326
    1. Cell. 1995 Jan 13;80(1):7-10
    1. J Exp Med. 1995 Jul 1;182(1):75-85
    1. Prep Biochem. 1972;2(2):139-65

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj